AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyril M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ajapa Pharma Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glyril M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility for some patients. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are essential.

Uses of Glyril M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glyril M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyril M 2mg/500mg Extended-Release tablets should be administered with a meal.

Common Side effects of Glyril M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glyril M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Glyril M 2mg/500mg Tablet SR. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

How Glyril M 2mg/500mg Tablet SR works:

Glyril M SR tablets (2mg/500mg) combine glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyril M 2mg/500mg SR tablets with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glyril M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glyril M tablets (2mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glyril M 2mg/500mg SR tablets; dosage modification may be necessary. Consult your physician for guidance. Glyril M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyril M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glyril M 2mg/500mg Tablet SR :

Should you forget to take a Glyril M 2mg/500mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyril M 2mg/500mg Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glyril M 2mg/500mg Tablet SR

Store this medication in its original, tightly sealed container or packaging. Follow the storage guidelines provided on the label or packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glyril M 2mg/500mg Tablet SR can induce lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this infrequent adverse reaction to metformin poses a significant risk to individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia necessitate immediate discontinuation of Glyril M 2mg/500mg Tablet SR and prompt medical attention.
Glyril M 2mg/500mg extended-release tablets contain glimepiride and metformin. This medication treats type 2 diabetes mellitus by improving blood sugar control in adults when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. This combination is unsuitable for managing type 1 diabetes.
Glyril M 2mg/500mg sustained-release tablets may cause common side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged administration can result in vitamin B12 deficiency.
Glyril M 2mg/500mg SR tablets may induce vitamin B12 deficiency with prolonged use due to impaired intestinal absorption of the vitamin. Untreated deficiency can lead to anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Prophylactic supplemental vitamin B12 is recommended annually by some experts to mitigate these risks.
Glyril M 2mg/500mg SR tablets can induce hypoglycemia (low blood glucose). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremor. Hypoglycemic episodes are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are concurrently used. Therefore, consistent blood glucose monitoring is crucial. Readily available glucose sources, such as glucose tablets, honey, or fruit juice, should always be kept on hand.
Combining Glyril M 2mg/500mg sustained-release tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glyril M 2mg/500mg Tablet...
55
MRP 67
17% off